Literature DB >> 12557099

[Multimodal treatment strategy for Langerhans cell histiocytosis at head and neck manifestations].

G Becker1, M Bücheler, F Paulsen, C Denzlinger, C Belka, P K Plinkert.   

Abstract

Langerhans cell histiocytosis (LCH) is a rare disorder with different clinical features. An established standardized treatment does not exist.We present a case report of a patient with localized LCH of the temporal bone and discuss the interdisciplinary treatment strategies. We reviewed the international literature and summarized the current knowledge. Beside a wait and see policy in cases without symptomatic disease, surgery, radiotherapy or chemotherapy, and combinations of these options are used as treatment modalities. While surgery or radiotherapy are preferred in localized (symptomatic) lesions, stage-adapted chemotherapeutic regimens are the treatments of choice in disseminated disease. Treatment selection depends on the individual clinical features.

Entities:  

Mesh:

Year:  2003        PMID: 12557099     DOI: 10.1007/s00106-001-0618-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  1 in total

1.  Intralesional corticosteroid therapy for mandibular Langerhans cell histiocytosis preserving the intralesional tooth germ.

Authors:  Antonios Moralis; Martin Kunkel; Norbert Kleinsasser; Urs Müller-Richter; Torsten Eugen Reichert; Oliver Driemel
Journal:  Oral Maxillofac Surg       Date:  2008-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.